Solana Bordetella Complete Assay
Bordetella Pertussis Dna Assay System. 510(k) K181029, from Quidel Corporation (Athens, OH). Product code OZZ, class 2.
As of Nov 20, 2026, K181029 is an FDA 510(k) held by Quidel Corporation, substantially equivalent on Jul 15, 2018 after 88 days, with 1 recall tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 1
The Solana Bordetella Complete Assay is an in vitro diagnostic test for the qualitative detection of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having respiratory tract infection attributable to Bordetella pertussis and Bordetella parapertussis.
- ARIES Bordetella Assay; ARIES Bordetella Assay Protocol File KitK163626 · Luminex Corporation · May 2, 2017
| Started | Recall | Status |
|---|---|---|
| Mar 24, 2025 | Z-1948-2025It was determined that there could be a false positive rate of up to 16.7% for the affected lots associated with the Bordetella parapertussis (BPP) results (only) of the assay. | Open |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 18, 2018
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files